Application Note: The Corning® Synthemax™ Surface: A Synthetic Surface Supporting Long-Term Passage of Undifferentiated hESCs
13 March 2011

This application poster addresses the need for scalable, reproducible, low cost and regulatory-friendly technologies to enable clinical use of human embryonic stem cell (hESC)-based therapeutics. Here, the development of a fully synthetic, xeno-free surface for culture of undifferentiated hESCs is described.

Download PDF >>PDF Icon

Read the full article...

  Become a member
  • Quick and complete access to all application articles

  • Download 10,000+
    applications and methods

  • Make informed buying decisions


Already a member?

Log in for full access to the article




Remember me